For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260318:nRSR0147Xa&default-theme=true
RNS Number : 0147X Ilika plc 18 March 2026
18 March 2026
Ilika plc
('Ilika,' the 'Company,' or the 'Group')
Ilika Announces Positive Feedback on Safety Testing of Goliath Cells by UK
Defence Agency
Independent Test Results Support Defence Applications
Ilika (AIM: IKA), the UK pioneer in solid state battery technology, announces
it has received positive feedback from a UK defence agency on safety tests of
its batteries under battlefield conditions, highlighting the potential of the
technology for use in high-risk, mission-critical environments where safety is
paramount.
In December 2025, Ilika delivered prototypes to customers across multiple
industries, including an agency which advises the UK Ministry of Defence. The
prototypes were subjected to firing range tests, which showed that:
· A Goliath 10Ah cell could survive a single shot before a thermal
event was triggered by a second one
· Low state-of-charge 10Ah Goliath cells did not show a thermal event
· A Goliath cell showed a delayed reaction before entering thermal
runaway
· A Goliath cell reached a lower thermal runaway temperature than
conventional Nickel Cobalt Aluminium ("NCA") lithium-ion cells
· Despite Goliath 10Ah cells storing 3x the energy of conventional NCA
cells being tested under equivalent conditions in the same trial, the Goliath
cells had a similar thermal response
This independent validation follows the delivery of Goliath prototypes to
multiple customers in December 2025 and supports Ilika's ongoing engagement
with partners evaluating safety‑critical applications. Under certain abuse
conditions, conventional lithium-ion batteries can enter a state of thermal
runaway, which is a chain reaction in which the battery temperature rises
uncontrollably, leading to a fire or explosion.
A power sources subject matter expert for the UK defence agency said: "Ilika's
Goliath cells were screened alongside an extensive range of other battery
technologies (both experimental and mature) as part of our work to understand
the risk associated with increased electrification, and to understand which
battery technologies can offer improved safety over conventional lithium-ion.
We would be very interested in evaluating Ilika's technology further in
applications optimised for deployment in defence environments."
Graeme Purdy, CEO of Ilika, said: "Events in recent months have highlighted
that we live in times with a heightened security risk. Mobile energy storage
is important for many modern defence applications, including drones, and we
are working with experts in the field to identify the most appropriate avenues
for commercialising Goliath in this sector, alongside other applications where
enhanced safety provides a clear competitive advantage."
ENDS--
Enquiries:
Ilika Plc www.ilika.com (http://www.ilika.com/)
Graeme Purdy, Chief Executive
Via FTI Consulting
Jason Stewart, Chief Financial Officer
Cavendish Capital Markets Limited (Nomad and Broker) +44 (0)131 220 9772
Peter Lynch
+44 (0)131 220 9771
Neil McDonald
FTI Consulting (Comms Advisors) ilika@fticonsulting.com
Ben Brewerton
Elizabeth Adams
Dwight Burden
About Ilika plc
Ilika is a global expert in the development of solid-state battery technology
for electric vehicles, medical devices and consumer appliances. The Company's
pioneering next-generation technologies aim to provide scalable, affordable
alternatives to conventional batteries, to industries which need to
incorporate a smaller, lighter, and safer power source in their products.
The Company has two product lines. Its Stereax batteries are designed for
powering miniature medical implants, industrial wireless sensors and Internet
of Things (IoT) applications and the Goliath large format batteries are
designed for EV cars and cordless appliances.
Through its licensing business model, Ilika supplies its IP portfolio to both
OEMs and manufacturing partners in exchange for a license fee and future
royalties.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCSFLFIWEMSEFD
Copyright 2019 Regulatory News Service, all rights reserved